Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Marco Del Chiaro to Pancreatic Neoplasms

This is a "connection" page, showing publications Marco Del Chiaro has written about Pancreatic Neoplasms.

 
Connection Strength
  
 
 
32.545
  
  1. Oba A, Tanaka K, Inoue Y, Valente R, Rangelova E, Arnelo U, Ono Y, Sato T, Torphy RJ, Ito H, L?hr M, Takahashi Y, Schulick RD, Saiura A, Sparrelid E, Del Chiaro M. Pancreatectomies with vein resection: Two large institutions' experience of East and West. Pancreatology. 2025 Mar; 25(2):250-257.
    View in: PubMed
    Score: 0.541
  2. Sugawara T, Rodriguez Franco S, Sherman S, Kirsch MJ, Colborn K, Franklin O, Ishida J, Grandi S, Al-Musawi MH, Gleisner A, Schulick RD, Del Chiaro M. Characteristics and prognosis of patients with pancreatic adenocarcinoma not expressing CA19-9: Analysis of the National Cancer Database. Pancreatology. 2024 Dec; 24(8):1340-1347.
    View in: PubMed
    Score: 0.534
  3. Stoop TF, Oba A, Wu YHA, Beaty LE, Colborn KL, Janssen BV, Al-Musawi MH, Franco SR, Sugawara T, Franklin O, Jain A, Saiura A, Sauvanet A, Coppola A, Javed AA, Groot Koerkamp B, Miller BN, Mack CE, Hashimoto D, Caputo D, Kleive D, Sereni E, Belfiori G, Ichida H, van Dam JL, Dembinski J, Akahoshi K, Roberts KJ, Tanaka K, Labori KJ, Falconi M, House MG, Sugimoto M, Tanabe M, Gotohda N, Krohn PS, Burkhart RA, Thakkar RG, Pande R, Dokmak S, Hirano S, Burgdorf SK, Crippa S, van Roessel S, Satoi S, White SA, Hackert T, Nguyen TK, Yamamoto T, Nakamura T, Bachu V, Burns WR, Inoue Y, Takahashi Y, Ushida Y, Aslami ZV, Verbeke CS, Fari?a A, He J, Wilmink JW, Messersmith W, Verheij J, Kaplan J, Schulick RD, Besselink MG, Del Chiaro M. Pathological Complete Response in Patients With Resected Pancreatic Adenocarcinoma After Preoperative Chemotherapy. JAMA Netw Open. 2024 06 03; 7(6):e2417625.
    View in: PubMed
    Score: 0.518
  4. Franklin O, Sugawara T, Ross RB, Rodriguez Franco S, Colborn K, Karam S, Schulick RD, Del Chiaro M. Adjuvant Chemotherapy With or Without Radiotherapy for Resected Pancreatic Cancer After Multiagent Neoadjuvant Chemotherapy. Ann Surg Oncol. 2024 Aug; 31(8):4966-4975.
    View in: PubMed
    Score: 0.517
  5. Yee EJ, Torphy RJ, Thielen ON, Easwaran L, Franklin O, Sugawara T, Bartsch C, Garduno N, McCarter MM, Ahrendt SA, Schulick RD, Del Chiaro M. Radiologic Occult Metastases in Pancreatic Cancer: Analysis of Risk Factors and Survival Outcomes in the Age of Contemporary Neoadjuvant Multi-agent Chemotherapy. Ann Surg Oncol. 2024 Sep; 31(9):6127-6137.
    View in: PubMed
    Score: 0.517
  6. Franklin O, Karam S, Schulick RD, Del Chiaro M. ASO Author Reflections: Is There a Role for Selective Adjuvant Radiotherapy in the Modern Era of Pancreatic Cancer Treatment? Ann Surg Oncol. 2024 Jul; 31(7):4695-4696.
    View in: PubMed
    Score: 0.514
  7. Del Chiaro M, Sugawara T, Karam SD, Messersmith WA. Advances in the management of pancreatic cancer. BMJ. 2023 12 13; 383:e073995.
    View in: PubMed
    Score: 0.501
  8. Arnelo U, Valente R, Scandavini CM, Halimi A, Mucelli RMP, Rangelova E, Svensson J, Schulick RD, Torphy RJ, Fagerstr?m N, Moro CF, Vujasinovic M, Matthias L?hr J, Del Chiaro M. Intraoperative pancreatoscopy can improve the detection of skip lesions during surgery for intraductal papillary mucinous neoplasia: A pilot study. Pancreatology. 2023 Sep; 23(6):704-711.
    View in: PubMed
    Score: 0.484
  9. Sugawara T, Rodriguez Franco S, Sherman S, Torphy RJ, Colborn K, Franklin O, Ishida J, Grandi S, Al-Musawi MH, Gleisner A, Schulick RD, Del Chiaro M. Neoadjuvant Chemotherapy Versus Upfront Surgery for Resectable Pancreatic Adenocarcinoma: An Updated Nationwide Study. Ann Surg. 2024 Feb 01; 279(2):331-339.
    View in: PubMed
    Score: 0.482
  10. Sugawara T, Rodriguez Franco S, Sherman S, Kirsch MJ, Colborn K, Ishida J, Grandi S, Al-Musawi MH, Gleisner A, Schulick RD, Del Chiaro M. Association of Adjuvant Chemotherapy in Patients With Resected Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy. JAMA Oncol. 2023 03 01; 9(3):316-323.
    View in: PubMed
    Score: 0.474
  11. Sugawara T, Franco SR, Ishida J, Kalra A, Saben JL, G?lvez KN, Kirsch MJ, Al-Musawi MH, Kaplan B, Pomfret EA, Schulick RD, Del Chiaro M. Prevalence and progression of intraductal papillary mucinous neoplasms of the pancreas in solid organ transplant recipients: A systematic review. Am J Transplant. 2023 03; 23(3):429-436.
    View in: PubMed
    Score: 0.470
  12. Oba A, Wu YHA, Schulick R, Del Chiaro M. Author response to: Comment on: Comparing neoadjuvant chemotherapy with or without radiation therapy for pancreatic ductal adenocarcinoma: National Cancer Database cohort analysis. Br J Surg. 2022 12 13; 110(1):112.
    View in: PubMed
    Score: 0.467
  13. Del Chiaro M, Kirsch MJ, Schulick R. Commentary on: Multi-institutional Validation Study of Cyst Fluid Protein Biomarkers in Patients With Cystic Lesions of the Pancreas. Ann Surg. 2022 08 01; 276(2):e133.
    View in: PubMed
    Score: 0.454
  14. Oba A, Wu YHA, Colborn KL, Karam SD, Meguid C, Al-Musawi MH, Bao QR, Gleisner AL, Ahrendt S, Schulick RD, Del Chiaro M. Comparing neoadjuvant chemotherapy with or without radiation therapy for pancreatic ductal adenocarcinoma: National Cancer Database cohort analysis. Br J Surg. 2022 04 19; 109(5):450-454.
    View in: PubMed
    Score: 0.447
  15. Valente R, Crippa S, Arnelo U, Vanella G, Zerboni G, Zarantonello L, Fogliati A, Arcidiacono PG, Vujasinovic M, Lohr JM, Falconi M, Capurso G, Del Chiaro M. The use of ace inhibitors influences the risk of progression of BD-IPMNs under follow-up. Pancreatology. 2022 May; 22(4):516-524.
    View in: PubMed
    Score: 0.445
  16. Oba A, Croce C, Hosokawa P, Meguid C, Torphy RJ, Al-Musawi MH, Ahrendt S, Gleisner A, Schulick RD, Del Chiaro M. Prognosis Based Definition of Resectability in Pancreatic Cancer: A Road Map to New Guidelines. Ann Surg. 2022 01 01; 275(1):175-181.
    View in: PubMed
    Score: 0.438
  17. Schulick RD, Oba A, Del Chiaro M. Response to the Comment on "Prognosis-based Definition of Resectability in Pancreatic Cancer: A Road Map to New Guidelines". Ann Surg. 2021 12 01; 274(6):e770-e771.
    View in: PubMed
    Score: 0.435
  18. Del Chiaro M, Torphy RJ, Schulick RD. Pancreatic incidentalomas: Investigation and management. J Intern Med. 2021 11; 290(5):969-979.
    View in: PubMed
    Score: 0.433
  19. Oba A, Wu YHA, Lieu CH, Meguid C, Colborn KL, Beaty L, Al-Musawi MH, Davis SL, Leal AD, Purcell T, King G, Wooten ES, Fujiwara Y, Goodman KA, Schefter T, Karam SD, Gleisner AL, Ahrendt S, Leong S, Messersmith WA, Schulick RD, Del Chiaro M. Outcome of neoadjuvant treatment for pancreatic cancer in elderly patients: comparative, observational cohort study. Br J Surg. 2021 08 19; 108(8):976-982.
    View in: PubMed
    Score: 0.427
  20. Crippa S, Fogliati A, Valente R, Sadr-Azodi O, Arnelo U, Capurso G, Halimi A, Partelli S, Ateeb Z, Arcidiacono PG, Lohr JM, Falconi M, Del Chiaro M. A tug-of-war in intraductal papillary mucinous neoplasms management: Comparison between 2017 International and 2018 European guidelines. Dig Liver Dis. 2021 08; 53(8):998-1003.
    View in: PubMed
    Score: 0.416
  21. Rangelova E, Wefer A, Persson S, Valente R, Tanaka K, Orsini N, Segersv?rd R, Arnelo U, Del Chiaro M. Surgery Improves Survival After Neoadjuvant Therapy for Borderline and Locally Advanced Pancreatic Cancer: A Single Institution Experience. Ann Surg. 2021 03 01; 273(3):579-586.
    View in: PubMed
    Score: 0.413
  22. He J, Schulick RD, Del Chiaro M. Landmark Series: Neoadjuvant Treatment in Borderline Resectable Pancreatic Cancer. Ann Surg Oncol. 2021 Mar; 28(3):1514-1520.
    View in: PubMed
    Score: 0.409
  23. Del Chiaro M, Schulick RD. Commentary on: Divestment or skeletonization of the SMA or the hepatic artery for locally advanced pancreatic ductal cancer after neoadjuvant therapy. Surgery. 2021 05; 169(5):1039-1040.
    View in: PubMed
    Score: 0.406
  24. Schulick AC, Moore HB, Schulick RD, Del Chiaro M. Thrombelastography as a Prognostic Tool in Adenocarcinoma of the Pancreas. Ann Surg. 2020 12; 272(6):e288-e289.
    View in: PubMed
    Score: 0.406
  25. Croce C, Mungo B, Oba A, Schulick RD, Del Chiaro M. ASO Author Reflections: Which Patients with Invasive Intraductal Papillary Mucinous Neoplasm Can Benefit from Adjuvant Therapy? Ann Surg Oncol. 2020 Dec; 27(Suppl 3):873-874.
    View in: PubMed
    Score: 0.400
  26. Stoop TF, Del Chiaro M. ASO Author Reflections: The Beneficial Effect of High-Volume Center Experience on Surgical Outcomes After Total Pancreatectomy. Ann Surg Oncol. 2020 Dec; 27(Suppl 3):878-879.
    View in: PubMed
    Score: 0.398
  27. Stoop TF, Ateeb Z, Ghorbani P, Scholten L, Arnelo U, Besselink MG, Del Chiaro M. Surgical Outcomes After Total Pancreatectomy: A High-Volume Center Experience. Ann Surg Oncol. 2021 Mar; 28(3):1543-1551.
    View in: PubMed
    Score: 0.397
  28. Mungo B, Croce C, Oba A, Ahrendt S, Gleisner A, Friedman C, Schulick RD, Del Chiaro M. Controversial Role of Adjuvant Therapy in Node-Negative Invasive Intraductal Papillary Mucinous Neoplasm. Ann Surg Oncol. 2021 Mar; 28(3):1533-1542.
    View in: PubMed
    Score: 0.397
  29. Oba A, Bao QR, Barnett CC, Al-Musawi MH, Croce C, Schulick RD, Del Chiaro M. Vascular Resections for Pancreatic Ductal Adenocarcinoma: Vascular Resections for PDAC. Scand J Surg. 2020 Mar; 109(1):18-28.
    View in: PubMed
    Score: 0.383
  30. Del Chiaro M, Valente R, Wolfgang C. Response to Comment on "Main Duct Dilatation is the Best Predictor of High-grade Dysplasia or Invasion in Intraductal Papillary Mucinous Neoplasms of the Pancreas". Ann Surg. 2019 12; 270(6):e109-e110.
    View in: PubMed
    Score: 0.379
  31. Rangelova E, Orsini N, Del Chiaro M. Response to Comment on "Surgery Improves Survival After Neoadjuvant Therapy for Borderline and Locally Advanced Pancreatic Cancer". Ann Surg. 2019 12; 270(6):e139-e141.
    View in: PubMed
    Score: 0.379
  32. Stoop TF, Del Chiaro M. ASO Author Reflections: Acceptable Impact of Endocrine and Exocrine Insufficiency on Quality of Life After Total Pancreatectomy. Ann Surg Oncol. 2020 Feb; 27(2):597-598.
    View in: PubMed
    Score: 0.376
  33. Stoop TF, Ateeb Z, Ghorbani P, Scholten L, Arnelo U, Besselink MG, Del Chiaro M. Impact of Endocrine and Exocrine Insufficiency on Quality of Life After Total Pancreatectomy. Ann Surg Oncol. 2020 Feb; 27(2):587-596.
    View in: PubMed
    Score: 0.374
  34. Del Chiaro M, Schulick RD. It is time for a biological definition of locally advanced pancreatic cancer. Br J Surg. 2019 08; 106(9):1257.
    View in: PubMed
    Score: 0.370
  35. Del Chiaro M, Arnelo U, Rangelova E, Valente R, Verbeke C. RE: Pancreatectomy with arterial resection. HPB (Oxford). 2019 09; 21(9):1254-1255.
    View in: PubMed
    Score: 0.369
  36. Gaiser RA, Pessia A, Ateeb Z, Davanian H, Fern?ndez Moro C, Alkharaan H, Healy K, Ghazi S, Arnelo U, Valente R, Velagapudi V, S?llberg Chen M, Del Chiaro M. Integrated targeted metabolomic and lipidomic analysis: A novel approach to classifying early cystic precursors to invasive pancreatic cancer. Sci Rep. 2019 07 15; 9(1):10208.
    View in: PubMed
    Score: 0.369
  37. Sakaguchi T, Valente R, Tanaka K, Satoi S, Del Chiaro M. Surgical treatment of metastatic pancreatic ductal adenocarcinoma: A?review of current literature. Pancreatology. 2019 Jul; 19(5):672-680.
    View in: PubMed
    Score: 0.366
  38. Ateeb Z, Valente R, Pozzi-Mucelli RM, Malgerud L, Schlieper Y, Rangelova E, Fernandez-Moro C, L?hr JM, Arnelo U, Del Chiaro M. Main pancreatic duct dilation greater than 6?mm is associated with an increased risk of high-grade dysplasia and cancer in IPMN patients. Langenbecks Arch Surg. 2019 Feb; 404(1):31-37.
    View in: PubMed
    Score: 0.356
  39. Del Chiaro M, Schulick RD. Use of Total Pancreatectomy and Preoperative Radiotherapy in Patients Undergoing Pancreatectomy with Artery Resection. J Am Coll Surg. 2019 01; 228(1):131.
    View in: PubMed
    Score: 0.356
  40. Del Chiaro M, S?reide K. Trials and tribulations of neoadjuvant therapy in pancreatic cancer. Br J Surg. 2018 10; 105(11):1387-1389.
    View in: PubMed
    Score: 0.349
  41. Del Chiaro M, Rangelova E, Halimi A, Ateeb Z, Scandavini C, Valente R, Segersv?rd R, Arnelo U, Verbeke CS. Pancreatectomy with arterial resection is superior to palliation in patients with borderline resectable or locally advanced pancreatic cancer. HPB (Oxford). 2019 02; 21(2):219-225.
    View in: PubMed
    Score: 0.346
  42. Keane MG, Shamali A, Nilsson LN, Antila A, Millastre Bocos J, Marijinissen Van Zanten M, Verdejo Gil C, Maisonneuve P, Vaalavuo Y, Hoskins T, Robinson S, Ceyhan GO, Abu Hilal M, Pereira SP, Laukkarinen J, Del Chiaro M. Risk of malignancy in resected pancreatic mucinous cystic neoplasms. Br J Surg. 2018 03; 105(4):439-446.
    View in: PubMed
    Score: 0.336
  43. Scandavini C, Valente R, Rangelova E, Segersv?rd R, Arnelo U, Permert J, Svensson PJ, Stenman J, Del Chiaro M. Pancreatectomies for pancreatic neoplasms in pediatric and adolescent age: A single institution experience. Pancreatology. 2018 Mar; 18(2):204-207.
    View in: PubMed
    Score: 0.331
  44. Del Chiaro M, Valente R, Arnelo U. Neoadjuvant Treatment in Locally Advanced and Borderline Resectable Pancreatic Cancer vs Primary Resectable Pancreatic Cancer. JAMA Surg. 2017 11 01; 152(11):1057.
    View in: PubMed
    Score: 0.328
  45. Del Chiaro M, Arnelo U, Valente R. Pancreatic Cystic Neoplasms: To Needle or Not To Needle, This Is the Question. Am J Gastroenterol. 2017 05; 112(5):804.
    View in: PubMed
    Score: 0.317
  46. Del Chiaro M, Valente R, Arnelo U. Minimally Invasive Pancreaticoduodenectomy for the Treatment of Pancreatic-Head and Periampullary Tumors. JAMA Surg. 2017 04 01; 152(4):343.
    View in: PubMed
    Score: 0.315
  47. Del Chiaro M, Verbeke C. Intraductal papillary mucinous neoplasms of the pancreas: reporting clinically relevant features. Histopathology. 2017 May; 70(6):850-860.
    View in: PubMed
    Score: 0.310
  48. Del Chiaro M, Ateeb Z, Hansson MR, Rangelova E, Segersv?rd R, Kartalis N, Ansorge C, L?hr MJ, Arnelo U, Verbeke C. Survival Analysis and Risk for Progression of Intraductal Papillary Mucinous Neoplasia of the Pancreas (IPMN) Under Surveillance: A Single-Institution Experience. Ann Surg Oncol. 2017 Apr; 24(4):1120-1126.
    View in: PubMed
    Score: 0.306
  49. Del Chiaro M, Rangelova E, Segersv?rd R, Arnelo U. Are there still indications for total pancreatectomy? Updates Surg. 2016 Sep; 68(3):257-263.
    View in: PubMed
    Score: 0.303
  50. Westermark S, Rangelova E, Ansorge C, Lundell L, Segersv?rd R, Del Chiaro M. Cattell-Braasch maneuver combined with local hypothermia during superior mesenteric artery resection in pancreatectomy. Langenbecks Arch Surg. 2016 Dec; 401(8):1241-1247.
    View in: PubMed
    Score: 0.302
  51. Del Chiaro M, Segersv?rd R, Rangelova E, Coppola A, Scandavini CM, Ansorge C, Verbeke C, Blomberg J. Cattell-Braasch Maneuver Combined with Artery-First Approach for Superior Mesenteric-Portal Vein Resection During Pancreatectomy. J Gastrointest Surg. 2015 Dec; 19(12):2264-8.
    View in: PubMed
    Score: 0.284
  52. Del Chiaro M, Verbeke CS, Kartalis N, Pozzi Mucelli R, Gustafsson P, Hansson J, Haas SL, Segersv?rd R, Andren-Sandberg ?, L?hr JM. Short-term Results of a Magnetic Resonance Imaging-Based Swedish Screening Program for Individuals at Risk for Pancreatic Cancer. JAMA Surg. 2015 Jun; 150(6):512-8.
    View in: PubMed
    Score: 0.277
  53. Marchegiani G, Malleo G, D'Haese JG, Wenzel P, Keskin M, Pugliese L, Borin A, Benning V, Nilsson L, Oruc N, Segersvard R, Friess H, Schmid R, L?hr M, Maisonneuve P, Bassi C, Ceyhan GO, Salvia R, Del Chiaro M. Association between pancreatic intraductal papillary mucinous neoplasms and extrapancreatic malignancies. Clin Gastroenterol Hepatol. 2015 Jun; 13(6):1162-9.
    View in: PubMed
    Score: 0.268
  54. Verbeke C, L?hr M, Karlsson JS, Del Chiaro M. Pathology reporting of pancreatic cancer following neoadjuvant therapy: challenges and uncertainties. Cancer Treat Rev. 2015 Jan; 41(1):17-26.
    View in: PubMed
    Score: 0.267
  55. Del Chiaro M, Segersv?rd R, Lohr M, Verbeke C. Early detection and prevention of pancreatic cancer: is it really possible today? World J Gastroenterol. 2014 Sep 14; 20(34):12118-31.
    View in: PubMed
    Score: 0.264
  56. Del Chiaro M, Mucelli RP, Blomberg J, Segersv?rd R, Verbeke C. Is intraductal tubulopapillary neoplasia a new entity in the spectrum of familial pancreatic cancer syndrome? Fam Cancer. 2014 Jun; 13(2):227-9.
    View in: PubMed
    Score: 0.259
  57. Del Chiaro M. Are there really indications for central pancreatectomy? JAMA Surg. 2014 Apr; 149(4):364.
    View in: PubMed
    Score: 0.256
  58. Del Chiaro M, Segersv?rd R, Pozzi Mucelli R, Rangelova E, Kartalis N, Ansorge C, Arnelo U, Blomberg J, L?hr M, Verbeke C. Comparison of preoperative conference-based diagnosis with histology of cystic tumors of the pancreas. Ann Surg Oncol. 2014 May; 21(5):1539-44.
    View in: PubMed
    Score: 0.252
  59. Del Chiaro M, Albiin N, Segersv?rd R. Enucleation of branch duct-IPMN in a transplant patient. Pancreatology. 2013 May-Jun; 13(3):312-3.
    View in: PubMed
    Score: 0.240
  60. Del Chiaro M, Verbeke C, Salvia R, Kl?ppel G, Werner J, McKay C, Friess H, Manfredi R, Van Cutsem E, L?hr M, Segersv?rd R. European experts consensus statement on cystic tumours of the pancreas. Dig Liver Dis. 2013 Sep; 45(9):703-11.
    View in: PubMed
    Score: 0.237
  61. Leonardi G, Marchi S, Falconi M, Zerbi A, Ussia V, de Bortoli N, Mosca F, Presciuttini S, Del Chiaro M. "PancPro" as a tool for selecting families eligible for pancreatic cancer screening: an Italian study of incident cases. Dig Liver Dis. 2012 Jul; 44(7):585-8.
    View in: PubMed
    Score: 0.220
  62. Del Chiaro M, Zerbi A, Capurso G, Zamboni G, Maisonneuve P, Presciuttini S, Arcidiacono PG, Calculli L, Falconi M. Familial pancreatic cancer in Italy. Risk assessment, screening programs and clinical approach: a position paper from the Italian Registry. Dig Liver Dis. 2010 Sep; 42(9):597-605.
    View in: PubMed
    Score: 0.196
  63. Del Chiaro M, Zerbi A, Falconi M, Bertacca L, Polese M, Sartori N, Boggi U, Casari G, Longoni BM, Salvia R, Caligo MA, Di Carlo V, Pederzoli P, Presciuttini S, Mosca F. Cancer risk among the relatives of patients with pancreatic ductal adenocarcinoma. Pancreatology. 2007; 7(5-6):459-69.
    View in: PubMed
    Score: 0.163
  64. Tajpara P, Sobkowiak MJ, Healy K, Naud S, G?ndel B, Halimi A, Khan ZA, Gabarrini G, Le Guyader S, Imreh G, Reisz JA, Del Chiaro M, D'Alessandro A, Heuchel R, L?hr JM, ?zenci V, S?llberg Chen M. Patient-derived pancreatic tumor bacteria exhibit oncogenic properties and are recognized by MAIT cells in tumor spheroids. Front Immunol. 2025; 16:1553034.
    View in: PubMed
    Score: 0.138
  65. Stoop TF, Sugawara T, Oba A, Feld IM, van Roessel S, van Veldhuisen E, Wu YHA, Nishino J, Ali M, Alseidi A, Sauvanet A, Mirabella A, Sa Cunha A, Kokkola A, Groot Koerkamp B, Pietrasz D, Kleive D, Butturini G, Malleo G, van Laarhoven HWM, Frigerio I, Dembinski J, He J, Gagni?re J, Kleeff J, Ramia JM, Roberts KJ, Labori KJ, Marino MV, Falconi M, B Mortensen M, Lesurtel M, Bonds M, Chatzizacharias N, Strobel O, Turrini O, Griffin O, Franklin O, Pfeiffer P, Schulick RD, Salvia R, de Wilde RF, Dokmak S, Rodriguez Franco S, Augustinus S, Burgdorf SK, Crippa S, Hackert T, Tarvainen T, Burns WR, Messersmith W, Wilmink JW, Burkhart RA, Del Chiaro M, Besselink MG. Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOX. JAMA Oncol. 2025 Mar 01; 11(3):276-287.
    View in: PubMed
    Score: 0.136
  66. Stoop TF, Seelen LWF, van 't Land FR, van der Hout AC, Scheepens JCM, Ali M, Stiggelbout AM, van der Kolk BM, Bonsing BA, Lips DJ, de Groot DJA, van Veldhuisen E, Kerver ED, Manusama ER, Daams F, Kazemier G, Cirkel GA, van Tienhoven G, Patijn GA, Lelieveld-Rier HN, de Hingh IH, van Hellemond IEG, Wijsman JH, Erdmann JI, Mieog JSD, de Vos-Geelen J, de Groot JWB, Lutchman KRD, Mekenkamp LJ, Kranenburg LW, Beuk LPM, Nijkamp MW, den Dulk M, Pol?e MB, Homs MYV, Wumkes ML, Stommel MWJ, Busch OR, de Wilde RF, Theijse RT, Luelmo SAC, Festen S, Bollen TL, Neumann UP, de Meijer VE, Draaisma WA, Groot Koerkamp B, Molenaar IQ, Wolfgang CL, Del Chiaro M, Katz MGH, Hackert T, Rietjens JAC, Wilmink JW, van Santvoort HC, van Eijck CHJ, Besselink MG. Nationwide implementation of the international multidisciplinary best-practice for locally advanced pancreatic cancer (PREOPANC-4): study protocol. BMC Cancer. 2025 Feb 19; 25(1):299.
    View in: PubMed
    Score: 0.136
  67. Rompen IF, Stoop TF, van Roessel S, van Veldhuisen E, Janssen QP, Alseidi A, Balduzzi A, Balzano G, Berrevoet F, Bonds M, Busch OR, Butturini G, Javed AA, Del Chiaro M, Conlon KC, Falconi M, Frigerio I, Fusai GK, Gagni?re J, Griffin O, Hackert T, Sparrelid E, Halimi A, Labori KJ, Malleo G, Marino MV, Mortensen MB, Nikov A, Lesurtel M, Keck T, Kleeff J, Pand? R, Pfeiffer P, Pietrasz D, Roberts KJ, Sa Cunha A, Salvia R, Strobel O, Tarvainen T, van Laarhoven HWM, Groot Koerkamp B, Loos M, Michalski CW, Besselink MG, Hank T. Validation of the PANAMA Score for Survival and Benefit of Adjuvant Therapy in Patients With Resected Pancreatic Cancer after Neoadjuvant FOLFIRINOX. Ann Surg. 2025 May 01; 281(5):852-860.
    View in: PubMed
    Score: 0.136
  68. Del Chiaro M, Boggi U, Presciuttini S, Bertacca L, Croce C, Mosca I, Mosca F. Genetics of pancreatic cancer: where are we now? Where are we going? JOP. 2005 Jan 13; 6(1 Suppl):60-7.
    View in: PubMed
    Score: 0.135
  69. Rangelova E, Stoop TF, van Ramshorst TME, Ali M, van Bodegraven EA, Javed AA, Hashimoto D, Steyerberg E, Banerjee A, Jain A, Sauvanet A, Serrablo A, Giani A, Giardino A, Zerbi A, Arshad A, Wijma AG, Coratti A, Zironda A, Socratous A, Rojas A, Halimi A, Ejaz A, Oba A, Patel BY, Bj?rnsson B, Reames BN, Tingstedt B, Goh BKP, Pay?-Llorente C, Del Pozo CD, Gonz?lez-Ab?s C, Medin C, van Eijck CHJ, de Ponthaud C, Takishita C, Schwabl C, M?nsson C, Ricci C, Thiels CA, Douchi D, Hughes DL, Kilburn D, Flanking D, Kleive D, Silva DS, Edil BH, Pando E, Moltzer E, Kauffman EF, Warren E, Bozkurt E, Sparrelid E, Thoma E, Verkolf E, Ausania F, Giannone F, H?ttner FJ, Burdio F, Souche FR, Berrevoet F, Daams F, Motoi F, Saliba G, Kazemier G, Roeyen G, Nappo G, Butturini G, Ferrari G, Kito Fusai G, Honda G, Sergeant G, Karteszi H, Takami H, Suto H, Matsumoto I, Mora-Oliver I, Frigerio I, Fabre JM, Chen J, Sham JG, Davide J, Urdzik J, de Martino J, Nielsen K, Okano K, Kamei K, Okada K, Tanaka K, Labori KJ, Goodsell KE, Alberici L, Webber L, Kirkov L, de Franco L, Miyashita M, Maglione M, Gramellini M, Ramera M, Amaral MJ, Ramaekers M, Truty MJ, van Dam MA, Stommel MWJ, Petrikowski M, Imamura M, Hayashi M, D'Hondt M, Brunner M, Hogg ME, Zhang C, Su?rez-Mu?oz M?, Luyer MD, Unno M, Mizuma M, Janot M, Sahakyan MA, Jamieson NB, Busch OR, Bilge O, Belyaev O, Franklin O, S?nchez-Vel?zquez P, Pessaux P, Holka PS, Ghorbani P, Casadei R, Sartoris R, Schulick RD, Gr?tzmann R, Sutcliffe R, Mata R, Patel RB, Takahashi R, Rodriguez Franco S, Cab?s SS, Hirano S, Gaujoux S, Festen S, Kozono S, Maithel SK, Chai SM, Yamaki S, van Laarhoven S, Mieog JSD, Murakami T, Codjia T, Sumiyoshi T, Karsten TM, Nakamura T, Sugawara T, Boggi U, Hartman V, de Meijer VE, Bartholom? W, Kwon W, Koh YX, Cho Y, Takeyama Y, Inoue Y, Nagakawa Y, Kawamoto Y, Ome Y, Soonawalla Z, Uemura K, Wolfgang CL, Jang JY, Padbury R, Satoi S, Messersmith W, Wilmink JW, Abu Hilal M, Besselink MG, Del Chiaro M. The impact of neoadjuvant therapy in patients with left-sided resectable pancreatic cancer: an international multicenter study. Ann Oncol. 2025 May; 36(5):529-542.
    View in: PubMed
    Score: 0.135
  70. Mark JA, Zheng Y, Franco SR, Khalaf RT, Trout AT, Nathan JD, Piester TL, Del Chiaro M, Abu El-Haija M, Wilsey MJ. Pancreatic Cystic Lesions in Children: A Comprehensive Scoping Review. Pancreas. 2025 Feb 01; 54(2):e150-e165.
    View in: PubMed
    Score: 0.134
  71. Habib JR, Kinny-K?ster B, Javed AA, Zelga P, Saadat LV, Kim RC, Gorris M, Allegrini V, Watanabe S, Sharib J, Arcerito M, Kaiser J, Lafaro KJ, Tu M, Bhandre M, Shi C, Kim MP, Correa C, Daamen LA, Oberstein PE, Schmidt CM, Hanna NN, Allen P, Loos M, Shrikhande SV, Molenaar IQ, Frigerio I, Katz MHG, Soares KC, Miao Y, Del Chiaro M, He J, Hackert T, Salvia R, B?chler MW, Castillo CF, Besselink MG, Marchegiani G, Wolfgang CL. Impact of Adjuvant Chemotherapy on Resected Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer: Results From an International Multicenter Study. J Clin Oncol. 2024 Dec 20; 42(36):4317-4326.
    View in: PubMed
    Score: 0.132
  72. Stoop TF, Augustinus S, Andersson B, Ghorbani P, Wellner UF, Uhl W, Besselink MG, Pitt HA, Del Chiaro M. ASO Author Reflections: Distal Pancreatectomy With and Without Portomesenteric Venous Resection for Pancreatic Adenocarcinoma: A Transatlantic Evaluation of Patients in North America, Germany, Sweden, and The Netherlands (GAPASURG). Ann Surg Oncol. 2024 Nov; 31(12):8354-8355.
    View in: PubMed
    Score: 0.131
  73. Stoop TF, Augustinus S, Bj?rnsson B, Tingstedt B, Andersson B, Wolfgang CL, Werner J, Johansen K, Stommel MWJ, Katz MHG, Ghadimi M, House MG, Ghorbani P, Molenaar IQ, de Wilde RF, Mieog JSD, Keck T, Wellner UF, Uhl W, Besselink MG, Pitt HA, Del Chiaro M. Surgical Outcome After Distal Pancreatectomy With and Without Portomesenteric Venous Resection in Patients with Pancreatic Adenocarcinoma: A Transatlantic Evaluation of Patients in North America, Germany, Sweden, and The Netherlands (GAPASURG). Ann Surg Oncol. 2024 Nov; 31(12):8327-8339.
    View in: PubMed
    Score: 0.131
  74. Yee EJ, Torphy RJ, Myers EK, Meguid C, Franklin O, Sugawara T, Franco SR, Clark TJ, Mungo B, Ahrendt SA, Schulick RD, Del Chiaro M, McCarter MM. Dynamic Anthropometrics in Pancreatic Cancer: Associations Between Body Composition Changes During Neoadjuvant Therapy and Survival Outcomes After Resection. Ann Surg Oncol. 2024 Nov; 31(12):8340-8351.
    View in: PubMed
    Score: 0.131
  75. Schulick AC, Moore HB, Franco SR, Jiang JG, Edil BH, Schulick RD, Nydam TL, McCarter MD, Del Chiaro M, Gleisner A. Gaining a new angle on pancreas cancer: A pre-operative thrombelastographic parameter predicts recurrence and survival among patients with resected periampullary and pancreatic adenocarcinoma. Am J Surg. 2024 Dec; 238:115820.
    View in: PubMed
    Score: 0.130
  76. McCranie A, Lee AD, Leonard L, Vemuru S, Huynh V, D'Angelo J, D'Angelo AL, Ahrendt G, Kaoutzanis C, Fisher C, Gleisner A, Meguid C, Schulick R, Del Chiaro M, Tevis S. Exploration of Patient Retention in Seeking a?Second Opinion: A Retrospective Cohort Study. J Surg Res. 2025 Feb; 306:588-603.
    View in: PubMed
    Score: 0.129
  77. Kazmi SZ, Jung HS, Han Y, Yun WG, Cho YJ, Lee M, Kwon W, Castillo CF, Del Chiaro M, Marchegiani G, Goh BKP, Hijioka S, Majumder S, Nakai Y, Shin A, Jang JY. Systematic review on surveillance for non-resected branch-duct intraductal papillary mucinous neoplasms of the pancreas. Pancreatology. 2024 May; 24(3):463-488.
    View in: PubMed
    Score: 0.127
  78. Boggi U, Kauffmann E, Napoli N, Barreto SG, Besselink MG, Fusai GK, Hackert T, Abu Hilal M, Marchegiani G, Salvia R, Shrikhande SV, Truty M, Werner J, Wolfgang CL, Bannone E, Capretti G, Cattelani A, Coppola A, Cucchetti A, De Sio D, Di Dato A, Di Meo G, Fiorillo C, Gianfaldoni C, Ginesini M, Hidalgo Salinas C, Lai Q, Miccoli M, Montorsi R, Pagnanelli M, Poli A, Ricci C, Sucameli F, Tamburrino D, Viti V, Addeo PF, Alfieri S, Bachellier P, Baiocchi GL, Balzano G, Barbarello L, Brolese A, Busquets J, Butturini G, Caniglia F, Caputo D, Casadei R, Chunhua X, Colangelo E, Coratti A, Costa F, Crafa F, Dalla Valle R, De Carlis L, de Wilde RF, Del Chiaro M, Di Benedetto F, Di Sebastiano P, Dokmak S, Hogg M, Egorov VI, Ercolani G, Ettorre GM, Falconi M, Ferrari G, Ferrero A, Filauro M, Giardino A, Grazi GL, Gruttadauria S, Izbicki JR, Jovine E, Katz M, Keck T, Khatkov I, Kiguchi G, Kooby D, Lang H, Lombardo C, Malleo G, Massani M, Mazzaferro V, Memeo R, Miao Y, Mishima K, Molino C, Nagakawa Y, Nakamura M, Nardo B, Panaro F, Pasquali C, Perrone V, Rangelova E, Liu R, Romagnoli R, Romito R, Rosso E, Schulick R, Siriwardena A, Spampinato MG, Strobel O, Testini M, Troisi RI, Uzunoglo FG, Valente R, Veneroni L, Zerbi A, Vicente E, Vistoli F, Vivarelli M, Wakabayashi G, Zanus G, Zureikat A, Zyromski NJ, Coppola R, D'Andrea V, Davide J, Dervenis C, Frigerio I, Konlon KC, Michelassi F, Montorsi M, Nealon W, Portolani N, Sousa Silva D, Bozzi G, Ferrari V, Trivella MG, Cameron J, Clavien PA, Asbun HJ. REDISCOVER International Guidelines on the Perioperative Care of Surgical Patients With Borderline-resectable and Locally Advanced Pancreatic Cancer. Ann Surg. 2024 Jul 01; 280(1):56-65.
    View in: PubMed
    Score: 0.127
  79. Gorris M, van Bodegraven EA, Abu Hilal M, Bolm L, Busch OR, Del Chiaro M, Habib J, Hasegawa K, He J, van Hooft JE, Jang JY, Javed AA, Kazami Y, Kwon W, Lee M, Liu R, Motoi F, Perri G, Saiura A, Salvia R, Sasanuma H, Takeda Y, Wolfgang C, Zelga P, Castillo CF, Marchegiani G, Besselink MG. Outcomes after distal pancreatectomy with or without splenectomy for intraductal papillary mucinous neoplasm: international multicentre cohort study. Br J Surg. 2024 Jan 03; 111(1).
    View in: PubMed
    Score: 0.126
  80. Stoop TF, Theijse RT, Seelen LWF, Groot Koerkamp B, van Eijck CHJ, Wolfgang CL, van Tienhoven G, van Santvoort HC, Molenaar IQ, Wilmink JW, Del Chiaro M, Katz MHG, Hackert T, Besselink MG. Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer. Nat Rev Gastroenterol Hepatol. 2024 Feb; 21(2):101-124.
    View in: PubMed
    Score: 0.125
  81. Hashimoto D, Satoi S, Fujii T, Sho M, He J, Hackert T, Del Chiaro M, Jang JY, Gulla A, Yoon YS, Shan YS, Lou W, Valente R, Furuse J, Oba A, Nagai M, Terai T, Tanaka H, Sakai A, Yamamoto T, Yamaki S, Matsumoto I, Murakami Y, Takaori K, Takeyama Y. Is surgical resection justified for pancreatic ductal adenocarcinoma with distant abdominal organ metastasis? A position paper by experts in pancreatic surgery at the Joint Meeting of the International Association of Pancreatology (IAP) & the Japan Pancreas Society (JPS) 2022 in Kyoto. Pancreatology. 2023 Sep; 23(6):682-688.
    View in: PubMed
    Score: 0.122
  82. Stuart CM, Kirsch MJ, Zhuang Y, Meguid CL, Sugawara T, Colborn KL, Messersmith W, Lieu C, Gleisner AL, Del Chiaro M, Schulick RD, Meguid RA. Pulmonary metastasectomy is associated with survival after lung-only recurrence in pancreatic cancer. Surgery. 2023 09; 174(3):654-659.
    View in: PubMed
    Score: 0.121
  83. Oba A, Del Chiaro M, Fujii T, Okano K, Stoop TF, Wu YHA, Maekawa A, Yoshida Y, Hashimoto D, Sugawara T, Inoue Y, Tanabe M, Sho M, Sasaki T, Takahashi Y, Matsumoto I, Sasahira N, Nagakawa Y, Satoi S, Schulick RD, Yoon YS, He J, Jang JY, Wolfgang CL, Hackert T, Besselink MG, Takaori K, Takeyama Y. "Conversion surgery" for locally advanced pancreatic cancer: A position paper by the study group at the joint meeting of the International Association of Pancreatology (IAP) & Japan Pancreas Society (JPS) 2022. Pancreatology. 2023 Sep; 23(6):712-720.
    View in: PubMed
    Score: 0.121
  84. Sugawara T, Rodriguez Franco S, Franklin O, Kirsch MJ, Colborn KL, Del Chiaro M, Schulick RD. Management of Localized Small- and Large-Cell Pancreatic Neuroendocrine Carcinoma in the National Cancer Database. J Am Coll Surg. 2023 09 01; 237(3):515-524.
    View in: PubMed
    Score: 0.120
  85. Djoumi Y, Sadr-Azodi O, Vujasinovic M, Del Chiaro M, Sparrelid E, Ghorbani P, Holmberg M. Pre-emptive resection for intraductal papillary mucinous neoplasia - Long-term outcome is similar between non-invasive and early invasive lesions in a tertiary single center. Pancreatology. 2023 Jun; 23(4):389-395.
    View in: PubMed
    Score: 0.119
  86. Sugawara T, Rodriguez Franco S, Kirsch MJ, Colborn KL, Ishida J, Grandi S, Al-Musawi MH, Gleisner A, Del Chiaro M, Schulick RD. Evaluation of Survival Following Surgical Resection for Small Nonfunctional Pancreatic Neuroendocrine Tumors. JAMA Netw Open. 2023 03 01; 6(3):e234096.
    View in: PubMed
    Score: 0.119
  87. van Huijgevoort NCM, Hoogenboom SAM, Lekkerkerker SJ, Busch OR, Del Chiaro M, Fockens P, Somers I, Verheij J, Voermans RP, Besselink MG, van Hooft JE. Diagnostic accuracy of the AGA, IAP, and European guidelines for detecting advanced neoplasia in intraductal papillary mucinous neoplasm/neoplasia. Pancreatology. 2023 Apr; 23(3):251-257.
    View in: PubMed
    Score: 0.118
  88. Madsen HJ, Carmichael H, Reinicke T, Gleisner AL, Del Chiaro M, Schulick RD, Stewart CL. Cannabis use and post-operative complications in patients undergoing pancreatic resection. HPB (Oxford). 2023 04; 25(4):431-438.
    View in: PubMed
    Score: 0.118
  89. Karam E, Hollenbach M, Ali EA, Auriemma F, Gulla A, Heise C, Regner S, Gaujoux S, Regimbeau JM, K?hler G, Seyfried S, Vaillant JC, De Ponthaud C, Sauvanet A, Birnbaum D, Regenet N, Truant S, P?rez-Cuadrado-Robles E, Bruzzi M, Lupinacci RM, Brunel M, Belfiori G, Barbier L, Salam? E, Souche FR, Schwarz L, Maggino L, Salvia R, Gagni?re J, Del Chiaro M, Leung G, Hackert T, Kleemann T, Paik WH, Caca K, Dugic A, Muehldorfer S, Schumacher B, Albers D. Outcomes of rescue procedures in the management of locally recurrent ampullary tumors: A Pancreas 2000/EPC study. Surgery. 2023 05; 173(5):1254-1262.
    View in: PubMed
    Score: 0.118
  90. Tamburrino D, Cortesi P, Facchetti R, de Pretis N, P?rez-Cuadrado-Robles E, Uribarri-Gonzalez L, Ateeb Z, Belfiori G, Arcidiacono PG, Mantovani LG, Del Chiaro M, Laukkarinen J, Falconi M, Crippa S, Capurso G. Real-world costs and dynamics of surveillance in patients who underwent surgery for low-risk branch duct intraductal papillary mucinous neoplasms. Eur J Surg Oncol. 2023 01; 49(1):137-141.
    View in: PubMed
    Score: 0.115
  91. Tamburrino D, de Pretis N, P?rez-Cuadrado-Robles E, Uribarri-Gonzalez L, Ateeb Z, Belfiori G, Maisonneuve P, Capurso G, Vanella G, Petrone MC, Arcidiacono PG, Vaalavuo Y, Frulloni L, Dominguez-Mu?oz JE, Deprez PH, Falconi M, Del Chiaro M, Crippa S, Laukkarinen J. Identification of patients with branch-duct intraductal papillary mucinous neoplasm and very low risk of cancer: multicentre study. Br J Surg. 2022 06 14; 109(7):617-622.
    View in: PubMed
    Score: 0.113
  92. Pozzi Mucelli RM, Moro CF, Del Chiaro M, Valente R, Blomqvist L, Papanikolaou N, L?hr JM, Kartalis N. Branch-duct intraductal papillary mucinous neoplasm (IPMN): Are cyst volumetry and other novel imaging features able to improve malignancy prediction compared to well-established resection criteria? Eur Radiol. 2022 Aug; 32(8):5144-5155.
    View in: PubMed
    Score: 0.111
  93. Piper M, Van Court B, Mueller A, Watanabe S, Bickett T, Bhatia S, Darragh LB, Mayeda M, Nguyen D, Gadwa J, Knitz M, Corbo S, Morgan R, Lee JJ, Dent A, Goodman K, Messersmith W, Schulick R, Del Chiaro M, Zhu Y, Kedl RM, Lenz L, Karam SD. Targeting Treg-Expressed STAT3 Enhances NK-Mediated Surveillance of Metastasis and Improves Therapeutic Response in Pancreatic Adenocarcinoma. Clin Cancer Res. 2022 Mar 01; 28(5):1013-1026.
    View in: PubMed
    Score: 0.111
  94. Nikolic S, Ghorbani P, Pozzi Mucelli R, Ghazi S, Baldaque-Silva F, Del Chiaro M, Sparrelid E, Verbeke CS, L?hr JM, Vujasinovic M. Surgery in Autoimmune Pancreatitis. Dig Surg. 2022; 39(1):32-41.
    View in: PubMed
    Score: 0.109
  95. Machairas N, Raptis DA, Vel?zquez PS, Sauvanet A, Rueda de Leon A, Oba A, Koerkamp BG, Lovasik B, Chan C, Yeo CJ, Bassi C, Ferrone CR, Kooby D, Moskal D, Tamburrino D, Yoon DS, Barroso E, de Santiba?es E, Kauffmann EF, Vigia E, Robin F, Casciani F, Burd?o F, Belfiori G, Malleo G, Lavu H, Hartog H, Hwang HK, Han HS, Marques HP, Poves I, Dom?nguez-Rosado I, Park JS, Lillemoe KD, Roberts K, Sulpice L, Besselink MG, Abuawwad M, Del Chiaro M, de Santiba?es M, Falconi M, D'Silva M, Silva M, Hilal MA, Qadan M, Sell NM, Beghdadi N, Napoli N, Busch ORC, Mazza O, Muiesan P, M?ller PC, Ravikumar R, Schulick R, Powell-Brett S, Abbas SH, Mackay TM, Stoop TF, Gallagher TK, Boggi U, van Eijck C, Clavien PA, Conlon KCP, Fusai GK. The Impact of Neoadjuvant Treatment on Survival in Patients Undergoing Pancreatoduodenectomy With Concomitant Portomesenteric Venous Resection: An International Multicenter Analysis. Ann Surg. 2021 11 01; 274(5):721-728.
    View in: PubMed
    Score: 0.108
  96. Oba A, Del Chiaro M, Satoi S, Kim SW, Takahashi H, Yu J, Hioki M, Tanaka M, Kato Y, Ariake K, Wu YHA, Inoue Y, Takahashi Y, Hackert T, Wolfgang CL, Besselink MG, Schulick RD, Nagakawa Y, Isaji S, Tsuchida A, Endo I. New criteria of resectability for pancreatic cancer: A position paper by the Japanese Society of Hepato-Biliary-Pancreatic Surgery (JSHBPS). J Hepatobiliary Pancreat Sci. 2022 Jul; 29(7):725-731.
    View in: PubMed
    Score: 0.108
  97. Verbeke C, Webster F, Brosens L, Campbell F, Del Chiaro M, Esposito I, Feakins RM, Fukushima N, Gill AJ, Kakar S, Kench JG, Krasinskas AM, van Laethem JL, Schaeffer DF, Washington K. Dataset for the reporting of carcinoma of the exocrine pancreas: recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology. 2021 Dec; 79(6):902-912.
    View in: PubMed
    Score: 0.107
  98. Torphy RJ, Friedman C, Halpern AL, Ahrendt SA, McCarter MD, Del Chiaro M, Schulick RD, Gleisner A. Implementation of Minimally Invasive Pancreaticoduodenectomy at Low and High-Volume Centers. J Surg Res. 2021 12; 268:720-728.
    View in: PubMed
    Score: 0.107
  99. Holmberg M, Ghorbani P, Gilg S, Del Chiaro M, Arnelo U, L?hr JM, Sparrelid E. Outcome after resection for invasive intraductal papillary mucinous neoplasia is similar to conventional pancreatic ductal adenocarcinoma. Pancreatology. 2021 Oct; 21(7):1371-1377.
    View in: PubMed
    Score: 0.107
  100. Kim HS, Song W, Choo W, Lee S, Han Y, Bassi C, Salvia R, Marchegiani G, Wolfgang CL, He J, Blair AB, Kluger MD, Su GH, Kim SC, Song KB, Yamamoto M, Hatori T, Yang CY, Yamaue H, Hirono S, Satoi S, Fujii T, Hirano S, Lou W, Hashimoto Y, Shimizu Y, Del Chiaro M, Valente R, Lohr M, Choi DW, Choi SH, Heo JS, Motoi F, Matsumoto I, Lee WJ, Kang CM, Shyr YM, Wang SE, Han HS, Yoon YS, Besselink MG, van Huijgevoort NCM, Sho M, Nagano H, Kim SG, Honda G, Yang Y, Yu HC, Yang JD, Chung JC, Nagakawa Y, Seo HI, Lee S, Kim H, Kwon W, Park T, Jang JY. Development, validation, and comparison of a nomogram based on radiologic findings for predicting malignancy in intraductal papillary mucinous neoplasms of the pancreas: An international multicenter study. J Hepatobiliary Pancreat Sci. 2023 Jan; 30(1):133-143.
    View in: PubMed
    Score: 0.104
  101. Tempero MA, Malafa MP, Al-Hawary M, Behrman SW, Benson AB, Cardin DB, Chiorean EG, Chung V, Czito B, Del Chiaro M, Dillhoff M, Donahue TR, Dotan E, Ferrone CR, Fountzilas C, Hardacre J, Hawkins WG, Klute K, Ko AH, Kunstman JW, LoConte N, Lowy AM, Moravek C, Nakakura EK, Narang AK, Obando J, Polanco PM, Reddy S, Reyngold M, Scaife C, Shen J, Vollmer C, Wolff RA, Wolpin BM, Lynn B, George GV. Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021 04 01; 19(4):439-457.
    View in: PubMed
    Score: 0.104
  102. Macinga P, Bajer L, Del Chiaro M, Chari ST, Dite P, Frulloni L, Ikeura T, Kamisawa T, Kubota K, Naitoh I, Okazaki K, Pezzilli R, Vujasinovic M, Spicak J, Hucl T, L?hr M. Pancreatic cancer in patients with autoimmune pancreatitis: A scoping review. Pancreatology. 2021 Aug; 21(5):928-937.
    View in: PubMed
    Score: 0.104
  103. Morgell A, Reisz JA, Ateeb Z, Davanian H, Reinsbach SE, Halimi A, Gaiser R, Valente R, Arnelo U, Del Chiaro M, Chen MS, D'Alessandro A. Metabolic Characterization of Plasma and Cyst Fluid from Cystic Precursors to Pancreatic Cancer Patients Reveal Metabolic Signatures of Bacterial Infection. J Proteome Res. 2021 05 07; 20(5):2725-2738.
    View in: PubMed
    Score: 0.104
  104. Mueller AC, Piper M, Goodspeed A, Bhuvane S, Williams JS, Bhatia S, Phan AV, Van Court B, Zolman KL, Pe?a B, Oweida AJ, Zakem S, Meguid C, Knitz MW, Darragh L, Bickett TE, Gadwa J, Mestroni L, Taylor MRG, Jordan KR, Dempsey P, Lucia MS, McCarter MD, Del Chiaro M, Messersmith WA, Schulick RD, Goodman KA, Gough MJ, Greene CS, Costello JC, Neto AG, Lagares D, Hansen KC, Van Bokhoven A, Karam SD. Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer. Cancer Res. 2021 06 15; 81(12):3255-3269.
    View in: PubMed
    Score: 0.103
  105. Fusai GK, Tamburrino D, Partelli S, Lykoudis P, Pipan P, Di Salvo F, Beghdadi N, Dokmak S, Wiese D, Landoni L, Nessi C, Busch ORC, Napoli N, Jang JY, Kwon W, Del Chiaro M, Scandavini C, Abu-Awwad M, Armstrong T, Hilal MA, Allen PJ, Javed A, Kjellman M, Sauvanet A, Bartsch DK, Bassi C, van Dijkum EJMN, Besselink MG, Boggi U, Kim SW, He J, Wolfgang CL, Falconi M. Portal vein resection during pancreaticoduodenectomy for pancreatic neuroendocrine tumors. An international multicenter comparative study. Surgery. 2021 05; 169(5):1093-1101.
    View in: PubMed
    Score: 0.102
  106. Zakem SJ, Mueller AC, Meguid C, Torphy RJ, Holt DE, Schefter T, Messersmith WA, McCarter MD, Del Chiaro M, Schulick RD, Goodman KA. Impact of neoadjuvant chemotherapy and stereotactic body radiation therapy (SBRT) on R0 resection rate for borderline resectable and locally advanced pancreatic cancer. HPB (Oxford). 2021 07; 23(7):1072-1083.
    View in: PubMed
    Score: 0.102
  107. van Roessel S, van Veldhuisen E, Klompmaker S, Janssen QP, Abu Hilal M, Alseidi A, Balduzzi A, Balzano G, Bassi C, Berrevoet F, Bonds M, Busch OR, Butturini G, Del Chiaro M, Conlon KC, Falconi M, Frigerio I, Fusai GK, Gagni?re J, Griffin O, Hackert T, Halimi A, Klaiber U, Labori KJ, Malleo G, Marino MV, Mortensen MB, Nikov A, Lesurtel M, Keck T, Kleeff J, Pand? R, Pfeiffer P, Pietrasz D, Roberts KJ, Sa Cunha A, Salvia R, Strobel O, Tarvainen T, Bossuyt PM, van Laarhoven HWM, Wilmink JW, Groot Koerkamp B, Besselink MG. Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment. JAMA Oncol. 2020 Nov 01; 6(11):1733-1740.
    View in: PubMed
    Score: 0.101
  108. Oweida AJ, Mueller AC, Piper M, Milner D, Van Court B, Bhatia S, Phan A, Bickett T, Jordan K, Proia T, Schulick R, Messersmith WA, Del Chiaro M, Clambey E, Gough MJ, Williams J, Hansen K, Goodman K, Karam SD. Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotide. Cancer Immunol Immunother. 2021 Apr; 70(4):989-1000.
    View in: PubMed
    Score: 0.101
  109. Alkharaan H, Lu L, Gabarrini G, Halimi A, Ateeb Z, Sobkowiak MJ, Davanian H, Fern?ndez Moro C, Jansson L, Del Chiaro M, ?zenci V, S?llberg Chen M. Circulating and Salivary Antibodies to Fusobacterium nucleatum Are Associated With Cystic Pancreatic Neoplasm Malignancy. Front Immunol. 2020; 11:2003.
    View in: PubMed
    Score: 0.100
  110. Oba A, Stoop TF, L?hr M, Hackert T, Zyromski N, Nealon WH, Unno M, Schulick RD, Al-Musawi MH, Wu W, Zhao Y, Satoi S, Wolfgang CL, Abu Hilal M, Besselink MG, Del Chiaro M. Global Survey on Pancreatic Surgery During the COVID-19 Pandemic. Ann Surg. 2020 08; 272(2):e87-e93.
    View in: PubMed
    Score: 0.099
  111. Wu YHA, Samuels JM, Harnke B, Negrini D, Al-Musawi MH, Meguid C, Ahrendt S, Schulick RD, Del Chiaro M, Oba A. Multifocal/diffuse pancreatic serous cystic neoplasms: Systematic review with a new case. Pancreatology. 2020 Jul; 20(5):902-909.
    View in: PubMed
    Score: 0.098
  112. van Roessel S, Strijker M, Steyerberg EW, Groen JV, Mieog JS, Groot VP, He J, De Pastena M, Marchegiani G, Bassi C, Suhool A, Jang JY, Busch OR, Halimi A, Zarantonello L, Groot Koerkamp B, Samra JS, Mittal A, Gill AJ, Bolm L, van Eijck CH, Abu Hilal M, Del Chiaro M, Keck T, Alseidi A, Wolfgang CL, Malleo G, Besselink MG. International validation and update of the Amsterdam model for prediction of survival after pancreatoduodenectomy for pancreatic cancer. Eur J Surg Oncol. 2020 05; 46(5):796-803.
    View in: PubMed
    Score: 0.095
  113. Goggins M, Overbeek KA, Brand R, Syngal S, Del Chiaro M, Bartsch DK, Bassi C, Carrato A, Farrell J, Fishman EK, Fockens P, Gress TM, van Hooft JE, Hruban RH, Kastrinos F, Klein A, Lennon AM, Lucas A, Park W, Rustgi A, Simeone D, Stoffel E, Vasen HFA, Cahen DL, Canto MI, Bruno M. Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. Gut. 2020 01; 69(1):7-17.
    View in: PubMed
    Score: 0.094
  114. van Huijgevoort NCM, Del Chiaro M, Wolfgang CL, van Hooft JE, Besselink MG. Diagnosis and management of?pancreatic cystic neoplasms: current evidence and guidelines. Nat Rev Gastroenterol Hepatol. 2019 11; 16(11):676-689.
    View in: PubMed
    Score: 0.093
  115. Held T, Verbeke CS, Strobel O, Rutkowski W, Villard C, Moro CF, Del Chiaro M, B?chler M, Heuchel R, L?hr M. Immunohistochemical profiling of liver metastases and matched-pair analysis in patients with metastatic pancreatic ductal adenocarcinoma. Pancreatology. 2019 Oct; 19(7):963-970.
    View in: PubMed
    Score: 0.093
  116. Scholten L, Stoop TF, Del Chiaro M, Busch OR, van Eijck C, Molenaar IQ, de Vries JH, Besselink MG. Systematic review of functional outcome and quality of life after total pancreatectomy. Br J Surg. 2019 12; 106(13):1735-1746.
    View in: PubMed
    Score: 0.093
  117. Moore HB, Culp-Hill R, Reisz JA, Lawson PJ, Sauaia A, Schulick RD, Del Chiaro M, Nydam TL, Moore EE, Hansen KC, D'Alessandro A. The metabolic time line of pancreatic cancer: Opportunities to improve early detection of adenocarcinoma. Am J Surg. 2019 12; 218(6):1206-1212.
    View in: PubMed
    Score: 0.093
  118. Jung W, Park T, Kim Y, Park H, Han Y, He J, Wolfgang CL, Blair A, Rashid MF, Kluger MD, Su GH, Chabot JA, Yang CY, Lou W, Valente R, Del Chiaro M, Shyr YM, Wang SE, van Huijgevoort NCM, Besselink MG, Yang Y, Kim H, Kwon W, Kim SW, Jang JY. Validation of a nomogram to predict the risk of cancer in patients with intraductal papillary mucinous neoplasm and main duct dilatation of 10?mm or less. Br J Surg. 2019 12; 106(13):1829-1836.
    View in: PubMed
    Score: 0.093
  119. Torphy RJ, Chapman BC, Friedman C, Nguyen C, Bartsch CG, Meguid C, Ahrendt SA, McCarter MD, Del Chiaro M, Schulick RD, Edil BH, Gleisner A. Quality of Life Following Major Laparoscopic or Open Pancreatic Resection. Ann Surg Oncol. 2019 Sep; 26(9):2985-2993.
    View in: PubMed
    Score: 0.092
  120. Arnelo U, Rangelova E, Del Chiaro M, Valente R, Verbeke C. RE: correct reporting is of utmost importance when a controversial treatment is being evaluated. HPB (Oxford). 2019 09; 21(9):1251-1252.
    View in: PubMed
    Score: 0.091
  121. Gaiser RA, Halimi A, Alkharaan H, Lu L, Davanian H, Healy K, Hugerth LW, Ateeb Z, Valente R, Fern?ndez Moro C, Del Chiaro M, S?llberg Chen M. Enrichment of oral microbiota in early cystic precursors to invasive pancreatic cancer. Gut. 2019 12; 68(12):2186-2194.
    View in: PubMed
    Score: 0.090
  122. Misra S, Moro CF, Del Chiaro M, Pouso S, Sebesty?n A, L?hr M, Bj?rnstedt M, Verbeke CS. Ex vivo organotypic culture system of precision-cut slices of human pancreatic ductal adenocarcinoma. Sci Rep. 2019 02 14; 9(1):2133.
    View in: PubMed
    Score: 0.090
  123. van Hilst J, de Rooij T, Klompmaker S, Rawashdeh M, Aleotti F, Al-Sarireh B, Alseidi A, Ateeb Z, Balzano G, Berrevoet F, Bj?rnsson B, Boggi U, Busch OR, Butturini G, Casadei R, Del Chiaro M, Chikhladze S, Cipriani F, van Dam R, Damoli I, van Dieren S, Dokmak S, Edwin B, van Eijck C, Fabre JM, Falconi M, Farges O, Fern?ndez-Cruz L, Forgione A, Frigerio I, Fuks D, Gavazzi F, Gayet B, Giardino A, Groot Koerkamp B, Hackert T, Hassenpflug M, Kabir I, Keck T, Khatkov I, Kusar M, Lombardo C, Marchegiani G, Marshall R, Menon KV, Montorsi M, Orville M, de Pastena M, Pietrabissa A, Poves I, Primrose J, Pugliese R, Ricci C, Roberts K, R?sok B, Sahakyan MA, S?nchez-Cab?s S, Sandstr?m P, Scovel L, Solaini L, Soonawalla Z, Souche FR, Sutcliffe RP, Tiberio GA, Tomazic A, Troisi R, Wellner U, White S, Wittel UA, Zerbi A, Bassi C, Besselink MG, Abu Hilal M. Minimally Invasive versus Open Distal Pancreatectomy for Ductal Adenocarcinoma (DIPLOMA): A Pan-European Propensity Score Matched Study. Ann Surg. 2019 01; 269(1):10-17.
    View in: PubMed
    Score: 0.089
  124. Meng Q, Valentini D, Rao M, Moro CF, Paraschoudi G, J?ger E, Dodoo E, Rangelova E, Del Chiaro M, Maeurer M. Neoepitope targets of tumour-infiltrating lymphocytes from patients with pancreatic cancer. Br J Cancer. 2019 01; 120(1):97-108.
    View in: PubMed
    Score: 0.088
  125. Loizou L, Duran CV, Axelsson E, Andersson M, Keussen I, Strinnholm J, Bartholom? W, Del Chiaro M, Segersv?rd R, Lundell L, Kartalis N. Radiological assessment of local resectability status in patients with pancreatic cancer: Interreader agreement and reader performance in two different classification systems. Eur J Radiol. 2018 Sep; 106:69-76.
    View in: PubMed
    Score: 0.086
  126. Klompmaker S, van Hilst J, Gerritsen SL, Adham M, Teresa Albiol Quer M, Bassi C, Berrevoet F, Boggi U, Busch OR, Cesaretti M, Dalla Valle R, Darnis B, De Pastena M, Del Chiaro M, Gr?tzmann R, Diener MK, Dumitrascu T, Friess H, Ivanecz A, Karayiannakis A, Fusai GK, Labori KJ, Lombardo C, L?pez-Ben S, Mabrut JY, Niesen W, Pardo F, Perinel J, Popescu I, Roeyen G, Sauvanet A, Prasad R, Sturesson C, Lesurtel M, Kleeff J, Salvia R, Besselink MG. Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort Study. Ann Surg Oncol. 2018 May; 25(5):1440-1447.
    View in: PubMed
    Score: 0.084
  127. Del Chiaro M, Schulick RD. Main-duct Intraductal Papillary Mucinous Neoplasm. High Cancer Risk in Duct Diameter of 5 to 9 mm. Ann Surg. 2017 12; 266(6):e86.
    View in: PubMed
    Score: 0.082
  128. Morelli L, Di Franco G, Guadagni S, Palmeri M, Furbetta N, Gianardi D, Del Chiaro M, Di Candio G, Mosca F. Technical Details and Results of a Modified End-to-Side Technique of Pancreatojejunostomy: a Personal Series of 100 Patients. J Gastrointest Surg. 2017 Dec; 21(12):2090-2099.
    View in: PubMed
    Score: 0.081
  129. Malgerud L, Lindberg J, Wirta V, Gustafsson-Liljefors M, Karimi M, Moro CF, Stecker K, Picker A, Huelsewig C, Stein M, Bohnert R, Del Chiaro M, Haas SL, Heuchel RL, Permert J, Maeurer MJ, Brock S, Verbeke CS, Engstrand L, Jackson DB, Gr?nberg H, L?hr JM. Bioinformatory-assisted analysis of next-generation sequencing data for precision medicine in pancreatic cancer. Mol Oncol. 2017 10; 11(10):1413-1429.
    View in: PubMed
    Score: 0.081
  130. Vujasinovic M, Valente R, Del Chiaro M, Permert J, L?hr JM. Pancreatic Exocrine Insufficiency in Pancreatic Cancer. Nutrients. 2017 Feb 23; 9(3).
    View in: PubMed
    Score: 0.078
  131. Fern?ndez Moro C, Fernandez-Woodbridge A, Alistair D'souza M, Zhang Q, Bozoky B, Kandaswamy SV, Catalano P, Heuchel R, Shtembari S, Del Chiaro M, Danielsson O, Bj?rnstedt M, L?hr JM, Isaksson B, Verbeke C, Boz?ky B. Immunohistochemical Typing of Adenocarcinomas of the Pancreatobiliary System Improves Diagnosis and Prognostic Stratification. PLoS One. 2016; 11(11):e0166067.
    View in: PubMed
    Score: 0.077
  132. Nilsson LN, Keane MG, Shamali A, Millastre Bocos J, Marijinissen van Zanten M, Antila A, Verdejo Gil C, Del Chiaro M, Laukkarinen J. Nature and management of pancreatic mucinous cystic neoplasm (MCN): A systematic review of the literature. Pancreatology. 2016 Nov - Dec; 16(6):1028-1036.
    View in: PubMed
    Score: 0.076
  133. Marconi S, Pugliese L, Del Chiaro M, Pozzi Mucelli R, Auricchio F, Pietrabissa A. An innovative strategy for the identification and 3D reconstruction of pancreatic cancer from CT images. Updates Surg. 2016 Sep; 68(3):273-278.
    View in: PubMed
    Score: 0.076
  134. Insulander J, Sanjeevi S, Haghighi M, Ivanics T, Analatos A, Lundell L, Del Chiaro M, Andr?n-Sandberg ?, Ansorge C. Prognosis following surgical bypass compared with laparotomy alone in unresectable pancreatic adenocarcinoma. Br J Surg. 2016 Aug; 103(9):1200-8.
    View in: PubMed
    Score: 0.074
  135. Pozzi-Mucelli RM, Rinta-Kiikka I, W?nsche K, Laukkarinen J, Labori KJ, ?nonsen K, Verbeke C, Del Chiaro M, Kartalis N. Pancreatic MRI for the surveillance of cystic neoplasms: comparison of a short with a comprehensive imaging protocol. Eur Radiol. 2017 Jan; 27(1):41-50.
    View in: PubMed
    Score: 0.074
  136. Loizou L, Albiin N, Leidner B, Axelsson E, Fischer MA, Grigoriadis A, Del Chiaro M, Segersv?rd R, Verbeke C, Sundin A, Kartalis N. Multidetector CT of pancreatic ductal adenocarcinoma: Effect of tube voltage and iodine load on tumour conspicuity and image quality. Eur Radiol. 2016 Nov; 26(11):4021-4029.
    View in: PubMed
    Score: 0.073
  137. Meng Q, Liu Z, Rangelova E, Poiret T, Ambati A, Rane L, Xie S, Verbeke C, Dodoo E, Del Chiaro M, L?hr M, Segersv?rd R, Maeurer MJ. Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer. J Immunother. 2016 Feb-Mar; 39(2):81-9.
    View in: PubMed
    Score: 0.073
  138. Sanjeevi S, Ivanics T, Lundell L, Kartalis N, Andr?n-Sandberg ?, Blomberg J, Del Chiaro M, Ansorge C. Impact of delay between imaging and treatment in patients with potentially curable pancreatic cancer. Br J Surg. 2016 Feb; 103(3):267-75.
    View in: PubMed
    Score: 0.072
  139. Jais B, Rebours V, Malleo G, Salvia R, Fontana M, Maggino L, Bassi C, Manfredi R, Moran R, Lennon AM, Zaheer A, Wolfgang C, Hruban R, Marchegiani G, Fern?ndez Del Castillo C, Brugge W, Ha Y, Kim MH, Oh D, Hirai I, Kimura W, Jang JY, Kim SW, Jung W, Kang H, Song SY, Kang CM, Lee WJ, Crippa S, Falconi M, Gomatos I, Neoptolemos J, Milanetto AC, Sperti C, Ricci C, Casadei R, Bissolati M, Balzano G, Frigerio I, Girelli R, Delhaye M, Bernier B, Wang H, Jang KT, Song DH, Huggett MT, Oppong KW, Pererva L, Kopchak KV, Del Chiaro M, Segersvard R, Lee LS, Conwell D, Osvaldt A, Campos V, Aguero Garcete G, Napoleon B, Matsumoto I, Shinzeki M, Bolado F, Fernandez JM, Keane MG, Pereira SP, Acuna IA, Vaquero EC, Angiolini MR, Zerbi A, Tang J, Leong RW, Faccinetto A, Morana G, Petrone MC, Arcidiacono PG, Moon JH, Choi HJ, Gill RS, Pavey D, Oua?ssi M, Sastre B, Spandre M, De Angelis CG, Rios-Vives MA, Concepcion-Martin M, Ikeura T, Okazaki K, Frulloni L, Messina O, L?vy P. Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumors of the Pancreas). Gut. 2016 Feb; 65(2):305-12.
    View in: PubMed
    Score: 0.069
  140. Pugliese L, Keskin M, Maisonneuve P, D'Haese JG, Marchegiani G, Wenzel P, Del Chiaro M, Ceyhan GO. Increased incidence of extrapancreatic neoplasms in patients with IPMN: Fact or fiction? A critical systematic review. Pancreatology. 2015 May-Jun; 15(3):209-16.
    View in: PubMed
    Score: 0.068
  141. Arnelo U, Siiki A, Swahn F, Segersv?rd R, Enochsson L, del Chiaro M, Lundell L, Verbeke CS, L?hr JM. Single-operator pancreatoscopy is helpful in the evaluation of suspected intraductal papillary mucinous neoplasms (IPMN). Pancreatology. 2014 Nov-Dec; 14(6):510-4.
    View in: PubMed
    Score: 0.066
  142. Del Chiaro M, Segersv?rd R. The state of the art of robotic pancreatectomy. Biomed Res Int. 2014; 2014:920492.
    View in: PubMed
    Score: 0.065
  143. Larghi A, Panic N, Capurso G, Leoncini E, Arzani D, Salvia R, Del Chiaro M, Frulloni L, Arcidiacono PG, Zerbi A, Manta R, Fabbri C, Ventrucci M, Tarantino I, Piciucchi M, Carnuccio A, Boggi U, Costamagna G, Delle Fave G, Pezzilli R, Bassi C, Bulajic M, Ricciardi W, Boccia S. Prevalence and risk factors of extrapancreatic malignancies in a large cohort of patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Ann Oncol. 2013 Jul; 24(7):1907-1911.
    View in: PubMed
    Score: 0.060
  144. Capurso G, Boccia S, Salvia R, Del Chiaro M, Frulloni L, Arcidiacono PG, Zerbi A, Manta R, Fabbri C, Ventrucci M, Tarantino I, Piciucchi M, Carnuccio A, Boggi U, Leoncini E, Costamagna G, Delle Fave G, Pezzilli R, Bassi C, Larghi A. Risk factors for intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a multicentre case-control study. Am J Gastroenterol. 2013 Jun; 108(6):1003-9.
    View in: PubMed
    Score: 0.059
  145. Piciucchi M, Crippa S, Del Chiaro M, Valente R, Pezzilli R, Falconi M, Delle Fave G, Capurso G. Outcomes of intraductal papillary mucinous neoplasm with "Sendai-positive" criteria for resection undergoing non-operative management. Dig Liver Dis. 2013 Jul; 45(7):584-8.
    View in: PubMed
    Score: 0.059
  146. Funel N, Giovannetti E, Pollina LE, del Chiaro M, Mosca F, Boggi U, Campani D. Critical role of laser microdissection for genetic, epigenetic and proteomic analyses in pancreatic cancer. Expert Rev Mol Diagn. 2011 Sep; 11(7):695-701.
    View in: PubMed
    Score: 0.053
  147. Funel N, Morelli M, Giovannetti E, Del Chiaro M, Pollina LE, Mosca F, Boggi U, Cavazzana A, Campani D. Loss of heterozygosity status of D9S105 marker is associated with downregulation of Kr?ppel-like factor 4 expression in pancreatic ductal adenocarcinoma and pancreatic intraepithelial lesions. Pancreatology. 2011; 11(1):30-42.
    View in: PubMed
    Score: 0.052
  148. Funel N, Vasile E, Del Chiaro M, Boggi U, Falcone A, Campani D, Scarpa A, Giovannetti E. Correlation of basal EGFR expression with pancreatic cancer grading but not with clinical outcome after gemcitabine-based treatment. Ann Oncol. 2011 Feb; 22(2):482-4.
    View in: PubMed
    Score: 0.051
  149. Zerbi A, Capitanio V, Boninsegna L, Pasquali C, Rindi G, Delle Fave G, Del Chiaro M, Casadei R, Falconi M. Surgical treatment of pancreatic endocrine tumours in Italy: results of a prospective multicentre study of 262 cases. Langenbecks Arch Surg. 2011 Mar; 396(3):313-21.
    View in: PubMed
    Score: 0.050
  150. Hwang JH, Voortman J, Giovannetti E, Steinberg SM, Leon LG, Kim YT, Funel N, Park JK, Kim MA, Kang GH, Kim SW, Del Chiaro M, Peters GJ, Giaccone G. Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer. PLoS One. 2010 May 14; 5(5):e10630.
    View in: PubMed
    Score: 0.049
  151. Giovannetti E, Funel N, Peters GJ, Del Chiaro M, Erozenci LA, Vasile E, Leon LG, Pollina LE, Groen A, Falcone A, Danesi R, Campani D, Verheul HM, Boggi U. MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity. Cancer Res. 2010 Jun 01; 70(11):4528-38.
    View in: PubMed
    Score: 0.049
  152. Mazzeo S, Cappelli C, Battaglia V, Caramella D, Caproni G, Pontillo Contillo B, Del Chiaro M, Boggi U, Funel N, Pollina L, Campani D, Mosca F, Bartolozzi C. Multidetector CT in the evaluation of retroperitoneal fat tissue infiltration in ductal adenocarcinoma of the pancreatic head: correlation with histopathological findings. Abdom Imaging. 2010 Aug; 35(4):465-70.
    View in: PubMed
    Score: 0.046
  153. Boggi U, Del Chiaro M, Croce C, Vistoli F, Signori S, Moretto C, Amorese G, Mazzeo S, Cappelli C, Campani D, Mosca F. Prognostic implications of tumor invasion or adhesion to peripancreatic vessels in resected pancreatic cancer. Surgery. 2009 Nov; 146(5):869-81.
    View in: PubMed
    Score: 0.046
  154. Boraschi P, Donati F, Gigoni R, Salemi S, Faggioni L, Del Chiaro M, Boggi U, Bartolozzi C, Falaschi F. Secretin-stimulated multi-detector CT versus mangafodipir trisodium-enhanced MR imaging plus MRCP in characterization of non-metastatic solid pancreatic lesions. Dig Liver Dis. 2009 Nov; 41(11):829-37.
    View in: PubMed
    Score: 0.045
  155. Funel N, Giovannetti E, Del Chiaro M, Mey V, Pollina LE, Nannizzi S, Boggi U, Ricciardi S, Del Tacca M, Bevilacqua G, Mosca F, Danesi R, Campani D. Laser microdissection and primary cell cultures improve pharmacogenetic analysis in pancreatic adenocarcinoma. Lab Invest. 2008 Jul; 88(7):773-84.
    View in: PubMed
    Score: 0.043
  156. Mazzeo S, Cappelli C, Caramella D, Del Chiaro M, Campani D, Pollina L, Caproni G, Battaglia V, Belcari A, Funel N, Di Candio G, Forasassi F, Boggi U, Bevilacqua G, Mosca F, Bartolozzi C. Evaluation of vascular infiltration in resected patients for pancreatic cancer: comparison among multidetector CT, intraoperative findings and histopathology. Abdom Imaging. 2007 Nov; 32(6):737-42.
    View in: PubMed
    Score: 0.039
  157. Giovannetti E, Del Tacca M, Mey V, Funel N, Nannizzi S, Ricci S, Orlandini C, Boggi U, Campani D, Del Chiaro M, Iannopollo M, Bevilacqua G, Mosca F, Danesi R. Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine. Cancer Res. 2006 Apr 01; 66(7):3928-35.
    View in: PubMed
    Score: 0.037
  158. Bengala C, Guarneri V, Giovannetti E, Lencioni M, Fontana E, Mey V, Fontana A, Boggi U, Del Chiaro M, Danesi R, Ricci S, Mosca F, Del Tacca M, Conte PF. Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma. Br J Cancer. 2005 Jul 11; 93(1):35-40.
    View in: PubMed
    Score: 0.035
  159. Campani D, Esposito I, Boggi U, Cecchetti D, Menicagli M, De Negri F, Colizzi L, Del Chiaro M, Mosca F, Fornaciari G, Bevilacqua G. Bcl-2 expression in pancreas development and pancreatic cancer progression. J Pathol. 2001 Aug; 194(4):444-50.
    View in: PubMed
    Score: 0.027
  160. Ansorge C, Nordin JZ, Lundell L, Str?mmer L, Rangelova E, Blomberg J, Del Chiaro M, Segersv?rd R. Diagnostic value of abdominal drainage in individual risk assessment of pancreatic fistula following pancreaticoduodenectomy. Br J Surg. 2014 Jan; 101(2):100-8.
    View in: PubMed
    Score: 0.016
  161. Boggi U, Del Chiaro M, Croce C, Amorese G, Signori S, Vistoli F, Di Candio G, Campatelli A, Morelli L, D'Imporzano S, Sgambelluri FA, Mosca I, Mosca F. Vascular complications of pancreatectomy. JOP. 2007 Jan 09; 8(1 Suppl):102-13.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)